If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    3.00 (1.42%)
Bid:
212.00
Ask:
217.00
Spread: 5.00 (2.358%)
Market Cap: £146.34m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Net Asset Value as at 31 March 2024

31 Jul 2024 07:00

RNS Number : 4772Y
Helios Underwriting Plc
31 July 2024
 

 

31 July 2024

Helios Underwriting plc

('Helios' or the 'Company')

 

Update on Net Asset Value as at 31st March 2024

 

Unaudited - NTA per share of 191p

 

Helios, the investment vehicle which builds shareholder value through exposure to Lloyd's, announces that the unaudited Net Asset Value per share has increased by 2p in the quarter to 31st March 2024 to £1.91.

 

Michel Wade, Executive Chairman, commented:

 

"The market conditions at Lloyd's remain strong, as reported across the market during the last month. Helios' pipeline profitability from the portfolio looks promising and underpins our confidence in the future performance of the business.

 

The recent repurchase of shares by the Company completed the Return of Capital to shareholders and has enhanced Net Asset Value per share."

 

Growth in Net Asset Value

Net Asset Value £ per share

Net Assets £000's

Net asset value per share as at 31/12/23

1.89

140,120

Profits for period to 31st March 2024 - Note 1

0.02

1,435

Share buy-backs

(807)

Unaudited Net Asset per Share - 31st March 2024

1.91

140,748

Basic Shares in issue at 31st March 2024

73,645

 

Note 1 - Profits to 31st March 2024 are management best estimate with the unaudited information at the date of publication.

 

Following the recent repurchase of shares valued at £3.7m by the Company a further enhancement of Net Asset Value per share is expected of approximately 2p per share.

 

For further information, please contact:

Helios Underwriting plc

Michael Wade - Executive Chairman

Arthur Manners - Chief Financial Officer

 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

 

FTI Consulting Ed Berry / Tom O'Brien +44 (0)7703 330 199 / +44 (0)7929 021 492 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £512m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVFLFVADAIIVIS
Date   Source Headline
3rd Jul 20267:11 amRNSResults of Scrip Dividend Election
1st Jul 20263:27 pmRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20267:00 amRNSNet Asset Value Update - Q1 2026
22nd Jun 20263:59 pmRNSResults of Annual General Meeting
22nd Jun 20269:00 amRNSTransaction in Own Shares
15th Jun 20269:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSScrip Dividend Reference Price
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.